Thomas Parkhouse

Thomas Parkhouse

Auto-generated profile, based on publicly available information

Thomas Parkhouse

University of Bristol

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in International Journal of Care and Caring
Verified
Journal Article
Open access
PDF file
FLFeylyn Lewis
Feylyn Lewis
SBSaul Becker
Saul Becker
TPThomas Parkhouse
Thomas Parkhouse
SJStephen Joseph
Stephen Joseph
Valentina HlebecValentina Hlebec
Valentina Hlebec
EHElizabeth Hanson
Elizabeth Hanson
For the first time, this article will provide a cross-national profile of adolescents who provide unpaid care to their ill or disabled family members in six European countries with varied levels of awareness, policy and service provision regarding adolescent young carers. Utilising an online survey, 2,099 adolescent young carers were identified in Italy, the Netherlands, Slovenia, Sweden, Switzerland and the UK. This article focuses on the impact of unpaid care on their mental health, well-being, physical health and education. Their preferences for informal and formal support were also examined. These groundbreaking findings help promote a ‘rights’ approach to adolescent young carers, which can serve as a critical driver for supportive policy creation on both a country-specific and pan-European level.

2 May 2025 in Addiction
Verified
Journal Article
Open access
MHMonika Halicka
Monika Halicka
TPThomas L. Parkhouse
Thomas L. Parkhouse
KWKatie Webster
Katie Webster
FSFrancesca Spiga
Francesca Spiga
LHLindsey A. Hines
Lindsey A. Hines
DCDeborah M. Caldwell
Deborah M. Caldwell
Aim: To evaluate the effectiveness, safety and cost‐effectiveness of psychosocial interventions for cannabis use disorder (CUD).Methods: A systematic review of randomized controlled trials (RCTs; PROSPERO protocol CRD42024553382) of psychosocial interventions for CUD lasting >4 sessions, delivered synchronously, to individuals with CUD aged ≥16 years, in inpatient, outpatient or community‐based settings. We searched databases (MEDLINE/PsycInfo/Cochrane CENTRAL) to 12 June 2024. We assessed results using Risk of Bias 2 and conducted pairwise meta‐analyses. Primary outcomes were continuous‐ and point‐abstinence and withdrawal intensity at the end of treatment, treatment completion and adverse events.Results: We included 22 RCTs (3304 participants). Relative to an inactive/non‐specific comparator, cognitive‐behavioural therapy with motivation enhancement (MET‐CBT) increased point abstinence [odds ratio (OR) = 18.27; 95% confidence interval (9.00−37.07)] and continuous abstinence [OR = 2.72; (1.20−6.19)], but reduced treatment completion [OR = 0.53; (0.35−0.85)]. Dialectical behavioural/acceptance and commitment therapy increased point abstinence versus inactive/non‐specific comparator [OR = 4.34; (1.74−10.80)]. The effect of MET‐CBT plus affect management versus MET‐CBT on point abstinence was OR = 7.85 (0.38−163.52). The effect of MET‐CBT plus abstinence‐based contingency management versus MET‐CBT on point abstinence was OR = 3.78 (0.83−17.25), and on continuous abstinence OR = 1.81 (0.61−5.41). For MET‐CBT plus abstinence‐contingency management versus MET‐CBT plus attendance‐contingency management, the effect on point abstinence was OR = 1.61 (0.72−3.60), and on continuous abstinence OR = 2.04 (0.75−5.58). The effect of community reinforcement on point abstinence was OR = 0.29 (0.04−1.90) versus MET‐CBT, and on continuous abstinence OR = 47.36 (16.00−140.21) versus non‐specific comparator. Interventions other than MET‐CBT may not affect treatment completion. No adverse events were reported. No study reported withdrawal intensity. Two economic evaluations reported higher costs for more complex interventions and contingency management.Conclusions: Cognitive‐behavioural therapy with motivation enhancement and dialectical behavioural/acceptance and commitment therapy may increase abstinence among people with cannabis use disorder relative to an inactive/non‐specific comparator. The conclusions remain tentative due to low‐ to very low‐certainty evidence and the small number of studies.

1 October 2024 in Health Technology Assessment
Verified
Journal Article
Open access
KWKatie E Webster
Katie E Webster
TPTom Parkhouse
Tom Parkhouse
SDSarah Dawson
Sarah Dawson
HJHayley E Jones
Hayley E Jones
EBEmily L Brown
Emily L Brown
JHJulian Pt Higgins
Julian Pt Higgins
Background: Acute respiratory infections are a common reason for consultation with primary and emergency healthcare services. Identifying individuals with a bacterial infection is crucial to ensure appropriate treatment. However, it is also important to avoid overprescription of antibiotics, to prevent unnecessary side effects and antimicrobial resistance. We conducted a systematic review to summarise evidence on the diagnostic accuracy of symptoms, signs and point-of-care tests to diagnose bacterial respiratory tract infection in adults, and to diagnose two common respiratory viruses, influenza and respiratory syncytial virus. Methods: The primary approach was an overview of existing systematic reviews. We conducted literature searches (22 May 2023) to identify systematic reviews of the diagnostic accuracy of point-of-care tests. Where multiple reviews were identified, we selected the most recent and comprehensive review, with the greatest overlap in scope with our review question. Methodological quality was assessed using the Risk of Bias in Systematic Reviews tool. Summary estimates of diagnostic accuracy (sensitivity, specificity or area under the curve) were extracted. Where no systematic review was identified, we searched for primary studies. We extracted sufficient data to construct a 2 × 2 table of diagnostic accuracy, to calculate sensitivity and specificity. Methodological quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies version 2 tool. Where possible, meta-analyses were conducted. We used GRADE to assess the certainty of the evidence from existing reviews and new analyses. Results: We identified 23 reviews which addressed our review question; 6 were selected as the most comprehensive and similar in scope to our review protocol. These systematic reviews considered the following tests for bacterial respiratory infection: individual symptoms and signs; combinations of symptoms and signs (in clinical prediction models); clinical prediction models incorporating C-reactive protein; and biological markers related to infection (including C-reactive protein, procalcitonin and others). We also identified systematic reviews that reported the accuracy of specific tests for influenza and respiratory syncytial virus. No reviews were found that assessed the diagnostic accuracy of white cell count for bacterial respiratory infection, or multiplex tests for influenza and respiratory syncytial virus. We therefore conducted searches for primary studies, and carried out meta-analyses for these index tests. Overall, we found that symptoms and signs have poor diagnostic accuracy for bacterial respiratory infection (sensitivity ranging from 9.6% to 89.1%; specificity ranging from 13.4% to 95%). Accuracy of biomarkers was slightly better, particularly when combinations of biomarkers were used (sensitivity 80–90%, specificity 82–93%). The sensitivity and specificity for influenza or respiratory syncytial virus varied considerably across the different types of tests. Tests involving nucleic acid amplification techniques (either single pathogen or multiplex tests) had the highest diagnostic accuracy for influenza (sensitivity 91–99.8%, specificity 96.8–99.4%). Limitations: Most of the evidence was considered low or very low certainty when assessed with GRADE, due to imprecision in effect estimates, the potential for bias and the inclusion of participants outside the scope of this review (children, or people in hospital). Future work: Currently evidence is insufficient to support routine use of point-of-care tests in primary and emergency care. Further work must establish whether the introduction of point-of-care tests adds value, or simply increases healthcare costs. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number NIHR159948.

EHElizabeth Hanson
Elizabeth Hanson
FBFrancesco Barbabella
Francesco Barbabella
LMLennart Magnusson
Lennart Magnusson
RBRosita Brolin
Rosita Brolin
MSMiriam Svensson
Miriam Svensson
SBSaul Becker
Saul Becker
Young carers are children and adolescents who provide care to other family members or friends, taking over responsibilities that are usually associated with adulthood. There is emerging but still scarce knowledge worldwide about the phenomenon of young carers and the impact of a caring role on their health, social and personal development spheres. This paper provides an overview of the main results from the ME-WE project, which is the first European research and innovation project dedicated to adolescent young carers (AYCs) (15–17 years). The project methods relied on three main activities: (1) a systematization of knowledge (by means of a survey to AYCs, country case studies, Delphi study, literature review); (2) the co-design, implementation and evaluation of a primary prevention intervention addressing AYCs’ mental health (by means of Blended Learning Networks and a clinical trial in six European countries); (3) the implementation of knowledge translation actions for dissemination, awareness, advocacy and lobbying (by means of national and international stakeholder networks, as well as traditional and new media). Project results substantially contributed to a better understanding of AYCs’ conditions, needs and preferences, defined tailored support intervention (resilient to COVID-19 related restrictions), and significant improvements in national and European policies for AYCs.

8 April 2025 in BMJ Medicine
Verified
Journal Article
Open access
PDF file
KWKatie E Webster
Katie E Webster
MHMonika Halicka
Monika Halicka
RBRussell J Bowater
Russell J Bowater
TPThomas Parkhouse
Thomas Parkhouse
DSDara Stanescu
Dara Stanescu
DCDeborah M. Caldwell
Deborah M. Caldwell
Objective: To assess whether relaxation and stress management techniques are useful in reducing blood pressure in individuals with hypertension and prehypertension. Design: Systematic review and network meta-analysis. Data sources: Medline, PsycInfo, and CENTRAL (Cochrane Central Register of Controlled Trials) from inception to 23 February 2024, and CINAHL (Cumulative Index to Nursing and Allied Health Literature) from inception to 27 February 2024. Eligibility criteria for selecting studies: Studies published in English of adults with hypertension (blood pressure ≥140/90 mm Hg) or prehypertension (blood pressure ≥120/80 mm Hg but <140/90 mm Hg). Studies that compared non-pharmacological interventions used to promote relaxation or reduce stress with each other, or with a control group (eg, no intervention, waiting list, or standard care). Where possible, network meta-analysis was used to compare the efficacy of the different interventions. Studies were assessed with the risk of bias 2 tool (RoB2), and those at high risk of bias were excluded from the primary analysis. The certainty of the evidence was assessed with CINeMA (Confidence in Network Meta-Analysis) and GRADE (Grading of Recommendations Assessment, Development, and Evaluation). Results: 182 studies were included (166 for hypertension and 16 for prehypertension). Results from a random effects network meta-analysis showed that, at short term follow-up (≤3 months), most relaxation interventions appeared to have a beneficial effect on systolic and diastolic blood pressure for individuals with hypertension. Between study heterogeneity was moderate (τ=2.62-4.73). Compared with a passive comparator (ie, no intervention, waiting list, or usual care), moderate reductions in systolic blood pressure were found for breathing control (mean difference −6.65 mm Hg, 95% credible interval −10.39 to −2.93), meditation (mean difference −7.71 mm Hg, −14.07 to −1.29), meditative movement (including tai chi and yoga, mean difference −9.58 mm Hg, −12.95 to −6.17), mindfulness (mean difference −9.90 mm Hg, −16.44 to −3.53), music (mean difference −6.61 mm Hg, −11.62 to −1.56), progressive muscle relaxation (mean difference −7.46 mm Hg, −12.15 to −2.96), psychotherapy (mean difference −9.83 mm Hg, −16.24 to −3.43), and multicomponent interventions (mean difference −6.78 mm Hg, −11.59 to −1.99). Reductions were also seen in diastolic blood pressure. Few studies conducted follow-up for more than three months, but effects on blood pressure seemed to lessen over time. Limited data were available for prehypertension; only two studies compared short term follow-up of relaxation therapies with a passive comparator, and the effects on systolic blood pressure were small (mean difference −3.84 mm Hg, 95% credible interval −6.25 to −1.43 for meditative movement; mean difference −0.53 mm Hg, −2.03 to 0.97 for multicomponent intervention). The certainty of the evidence was considered to be very low based on the CINeMA framework, owing to the risk of bias in the primary studies, potential publication bias, and imprecision in the effect estimates. Conclusions: The results of the study indicated that relaxation and stress management techniques might have beneficial short term effects on blood pressure for people with hypertension, but the effectiveness of these interventions is still uncertain. Future studies should ensure rigorous methods are used to minimise the risk of bias, and a longer duration of follow-up to establish whether these effects persist. Systematic review registration: PROSPERO CRD42023469128

25 January 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
RBRosita Brolin
Rosita Brolin
EHElizabeth Hanson
Elizabeth Hanson
LMLennart Magnusson
Lennart Magnusson
FLFeylyn Lewis
Feylyn Lewis
TPTom Parkhouse
Tom Parkhouse
SBSaul Becker
Saul Becker
A child’s disability, long-term illness, or mental ill-health is known to affect siblings’ health, social life, school engagement, and quality of life. This article addresses a research gap by its focus on young sibling carers and the impact of providing care to a sibling. A cross-national survey study was conducted in 2018–2019 (Italy, the Netherlands, Slovenia, Sweden, Switzerland, the UK) to examine the incidence of adolescent sibling carers, the extent of care they provide, and their self-reported health, well-being, and school situation. The survey was completed by 7146 adolescents, aged 15–17, and 1444 of them provided care to family members with health-related conditions. Out of these, 286 were identified as Sibling Carers and 668 as Parent Carers, while 181 had both sibling(s) and parent(s) with health-related conditions, and thus were identified as Sibling–Parent Carers. Sibling Carers and Sibling–Parent Carers carried out higher levels of caring activities compared to Parent Carers. They reported both positive aspects of caring, such as increased maturity, and negative aspects, such as mental ill-health, impact on schooling and a lack of support. To reduce the negative aspects of a sibling carer role, it is important to recognise them and to implement early preventive measures and formal support.